ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021)
ImmunityBio (IBRX) reported Interest & Investment Income of $112000.0 for Q2 2021, down 67.16% year-over-year from $341000.0 in Q2 2020, and down 98.75% quarter-over-quarter from $8.9 million in Q1 2021.
ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021) Analysis & Trends
ImmunityBio (IBRX) has 7 years of Interest & Investment Income data on file, last reported at $112000.0 in Q2 2021.
- Interest & Investment Income for Q2 2021 came in at $112000.0, down 67.16% year-over-year; the trailing twelve-month figure through Jun 2021 was $9.6 million (up 724.16% YoY), and the FY2020 annual result was $366000.0, down 77.72% from the prior year.
- Interest & Investment Income eased to $112000.0 in Q2 2021 per IBRX's latest filing, from $8.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $8.9 million in Q1 2021 and troughed at -$743000.0 in Q4 2017.
- A 5-year average of $889277.8 and a median of $440000.0 in 2018 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2017 and 2021: Interest & Investment Income sank 125.92% in 2017, then jumped 11366.67% in 2021.
- A 5-year view of Interest & Investment Income shows it stood at -$743000.0 in 2017, then soared by 155.85% to $415000.0 in 2018, then fell by 26.02% to $307000.0 in 2019, then plunged by 84.69% to $47000.0 in 2020, then jumped by 138.3% to $112000.0 in 2021.
- Business Quant data shows IBRX's Interest & Investment Income at $112000.0 in Q2 2021, $8.9 million in Q1 2021, and $47000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 8.94 Mn |
| Dec 31, 2020 | 47,000.00 |
| Sep 30, 2020 | 449,000.00 |
| Jun 30, 2020 | 341,000.00 |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 307,000.00 |
| Sep 30, 2019 | 433,000.00 |
| Jun 30, 2019 | 533,000.00 |
| Mar 31, 2019 | 410,000.00 |
| Dec 31, 2018 | 415,000.00 |
| Sep 30, 2018 | 447,000.00 |
| Jun 30, 2018 | 490,000.00 |
| Mar 31, 2018 | 704,000.00 |
| Dec 31, 2017 | -743,000.00 |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 681,000.00 |
| Mar 31, 2017 | 1.35 Mn |
| Dec 31, 2016 | 2.87 Mn |
| Sep 30, 2016 | 1.37 Mn |